Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIMI Regulatory News (IMI)

Share Price Information for IMI (IMI)

Share Price is delayed by 15 minutes
Get Live Data
2,828.00    0.00 (0.00%)
Bid:
2,828.00
Ask:
2,832.00
Spread: 4.00 (0.141%)
Market Cap: £6.73b
IMI Live PriceLast checked at - London Stock Exchange

Intraday IMI Share Chart

Interim Management Statement

9 May 2024 07:00

RNS Number : 6956N
IMI PLC
09 May 2024
Β 

9 May 2024

Β 

First quarter performance in line with expectations

Full year guidance reconfirmed

Β 

IMI, the specialist engineering company, issues the following Interim Management Statement which covers results for the first quarter from 1 January to 31 March 2024.

Β 

Roy Twite, Chief Executive, commented:

Β 

"We were pleased to deliver another solid quarter of organic growth, up 4% in the first quarter, in mixed markets and against a strong comparator. Based on current market conditions, our guidance remains unchanged and we still expect that 2024 full year adjusted EPS will be between 120p and 126p".

Β 

Encouraging first quarter performance

Β 

Group organic revenue was up 4% compared to the same period last year. Adjusted revenue was flat, reflecting the foreign currency movements seen in the first quarter.

Β 

Our restructuring programme remains on track to deliver Β£15m of incremental benefits for the full year and Β£7m in 2025, with no changes to expected delivery costs.

Β 

Sector performance in line with expectations

Β 

Automation

Β 

Automation (62% of 2023 sales) delivered a strong performance, with revenue up 12% organically.

Β 

Process Automation (37% of 2023 sales) had an excellent quarter as we saw continued momentum across our energy end markets and further progress in the Aftermarket. Organic revenue was 27% higher than the prior period. Orders were down 3% organically, due to the one-off Β£26m Marine order in the prior period.

Β 

Industrial Automation (25% of 2023 sales) organic revenue was 5% lower than the same period last year, reflecting the strong first quarter comparator and lower industrial activity in Europe and the Americas.

Β 

Life Technology

Β 

As expected, Life Technology (38% of 2023 sales) revenue was down 6% organically in the first quarter versus the same period last year. We continue to expect the platform to be broadly flat in the full year.

Β 

Climate Control (18% of 2023 sales) organic revenue was 4% lower than the prior period, as expected given the 12% organic growth delivered in the first quarter of 2023. Whilst dynamics in the European construction market did impact sales in the quarter, underlying demand for our energy efficient products remains strong.Β 

Β 

Life Science and Fluid Control (12% of 2023 sales) organic revenue was down 22%, as expected given the tough first quarter comparator and continued softness experienced across the global life sciences device market.

Β 

Transport (8% of 2023 sales) organic revenue grew 19% in the first quarter. We continue to benefit from strong growth in Asia and our new product launches, supported by favourable regulatory tailwinds.

Β 

Disposal of non-core business

Β 

On 25 April 2024 the Group disposed of Industrie MΓ©canique pour les Fluides, a non-core subsidiary within the Life Science & Fluid Control sector, for an enterprise value of €19m. The business contributed around 1% of sales and operating profit in 2023.

Β 

Exchange rates

Β 

If exchange rates as at 26 April 2024 of US$1.25 and €1.17 remain constant for the remainder of the year, we continue to expect a headwind on both revenue and adjusted operating profit of 2% in the 2024 full year when compared to 2023.

Β 

Outlook

Β 

Based on current market conditions, our guidance for 2024 full year adjusted EPS is unchanged at 120p to 126p.

Β 

Interim results

Β 

IMI will issue its interim results announcement in respect of the six months ending 30 June 2024 on 26 July 2024.

Β 

Enquiries

Β 

Luke Grant

IMI

Tel: +44 (0)7866 148 374

Matt Denham

Headland

Tel: +44 (0)7551 825 496

Β 

A conference call for analysts and investors will be held at 08:00 BST today to discuss this statement. To access the call, please register using the link:

Β 

https://www.netroadshow.com/events/login?show=ed69d8ce&confId=64057

Β 

Notes

Β 

IMI plc is a FTSE100 global specialist engineering company that designs, manufactures and services highly engineered products to control the precise movement of fluids. Its innovative motion and flow control technologies, built around valves and actuators, enable vital sectors to become safer, more sustainable and more productive. IMI combines world class applications engineering expertise with a continued focus on customer satisfaction, market-led innovation and complexity reduction to solve its customers most acute engineering problems. IMI employs approximately 10,000 people, has manufacturing facilities in 18 countries and operates a global service network. The Company is listed on the London Stock Exchange. Further information is available at www.imiplc.com.

Β 

References to adjusted figures reflect figures as reported to management and do not include the impact of adjusting items. References to organic changes are on a constant currency basis and exclude disposals and acquisitions.

Β 

IMI plc is registered in England No. 714275. Its legal entity identifier ('LEI') number is 2138002W9Q21PF751R30.

Β 

Β 

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
UPDBRGDUGSGDGSI
Date   Source Headline
2nd Jan 202411:35 amRNSBlock listing Interim Review
2nd Jan 202411:04 amRNSTotal Voting Rights
19th Dec 20239:55 amRNSDirector/PDMR Shareholding
13th Dec 20233:41 pmRNSDirector/PDMR Shareholding
5th Dec 20239:28 amRNSDirector Declaration
1st Dec 20231:30 pmRNSTotal Voting Rights
15th Nov 20231:42 pmRNSDirector/PDMR Shareholding
9th Nov 20237:01 amRNSHistorical Financial Information
9th Nov 20237:00 amRNSInterim Management Statement
1st Nov 202312:42 pmRNSTotal Voting Rights
11th Oct 20233:20 pmRNSDirector/PDMR Shareholding
2nd Oct 20231:19 pmRNSTotal Voting Rights
13th Sep 20233:32 pmRNSDirector/PDMR Shareholding
1st Sep 202311:29 amRNSTotal Voting Rights
10th Aug 20234:53 pmRNSDirector/PDMR Shareholding
10th Aug 20234:38 pmRNSDirector/PDMR Shareholding
9th Aug 20232:34 pmRNSDirector/PDMR Shareholding
1st Aug 202310:16 amRNSTotal Voting Rights
31st Jul 20231:52 pmRNSDirector/PDMR Shareholding
28th Jul 20237:00 amRNSInterim Results
12th Jul 20231:13 pmRNSDirector/PDMR Shareholding
3rd Jul 20232:58 pmRNSBlock listing Interim Review
3rd Jul 20232:41 pmRNSTotal Voting Rights
26th Jun 20234:39 pmRNSHolding(s) in Company
14th Jun 202310:48 amRNSDirector/PDMR Shareholding
8th Jun 20233:18 pmRNSDirector/PDMR Shareholding
1st Jun 20231:51 pmRNSTotal Voting Rights
22nd May 202310:18 amRNSDirectorate Change
11th May 202311:49 amRNSHolding(s) in Company
10th May 20232:40 pmRNSDirector/PDMR Shareholding
4th May 20231:05 pmRNSResult of AGM
4th May 20237:00 amRNSInterim Management Statement
2nd May 20232:46 pmRNSTotal Voting Rights
14th Apr 20233:18 pmRNSDirector/PDMR Shareholding
12th Apr 202311:29 amRNSDirector/PDMR Shareholding
3rd Apr 202311:38 amRNSTotal Voting Rights
29th Mar 20234:53 pmRNSHolding(s) in Company
27th Mar 202311:35 amRNSDirector/PDMR Shareholding
27th Mar 202311:25 amRNSDirector/PDMR Shareholding
24th Mar 20239:49 amRNSAnnual Financial Report
16th Mar 20239:28 amRNSHolding(s) in Company
15th Mar 20232:13 pmRNSDirector/PDMR Shareholding
8th Mar 20233:19 pmRNSDirector/PDMR Shareholding
3rd Mar 20237:00 amRNSPreliminary Results
1st Mar 20231:36 pmRNSTotal Voting Rights
15th Feb 202312:43 pmRNSDirector/PDMR Shareholding
1st Feb 202312:39 pmRNSTotal Voting Rights
26th Jan 202311:00 amRNSHolding(s) in Company
19th Jan 202310:07 amRNSHolding(s) in Company
11th Jan 20232:21 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.